{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:22:20Z","timestamp":1789399340228,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Tianjin Science and Technology Bureau","award":["24ZYCGSY00570"],"award-info":[{"award-number":["24ZYCGSY00570"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-04711-x","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T08:38:25Z","timestamp":1745483905000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The relationship between hemoglobin glycation index and all-cause mortality in ill critically patients with heart failure: a retrospective study in MIMIC-IV database"],"prefix":"10.1186","volume":"25","author":[{"given":"Yulong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haokun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongle","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"key":"4711_CR1","first-page":"e876","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145:e876\u201394.","journal-title":"Circulation"},{"key":"4711_CR2","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","volume":"147","author":"CW Tsao","year":"2023","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, et al. Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association. Circulation. 2023;147:e93\u2013621.","journal-title":"Circulation"},{"key":"4711_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2024.132304","volume":"412","author":"A Abdin","year":"2024","unstructured":"Abdin A, B\u00f6hm M, Shahim B, et al. Heart failure with preserved ejection fraction epidemiology, pathophysiology, diagnosis and treatment strategies. Int J Cardiol. 2024;412: 132304.","journal-title":"Int J Cardiol"},{"key":"4711_CR4","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S0140-6736(23)02756-3","volume":"403","author":"P Campbell","year":"2024","unstructured":"Campbell P, Rutten FH, Lee MM, et al. Heart failure with preserved ejection fraction: everything the clinician needs to know. Lancet. 2024;403:1083\u201392.","journal-title":"Lancet"},{"key":"4711_CR5","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.22190","volume":"3","author":"R Khera","year":"2020","unstructured":"Khera R, Kondamudi N, Zhong L, et al. Temporal Trends in Heart Failure Incidence Among Medicare Beneficiaries Across Risk Factor Strata, 2011 to 2016. JAMA Netw Open. 2020;3: e2022190.","journal-title":"JAMA Netw Open"},{"key":"4711_CR6","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/S2213-8587(16)00085-1","volume":"4","author":"N Sattar","year":"2016","unstructured":"Sattar N, Preiss D. Screening for diabetes in patients with cardiovascular disease: HbA1c trumps oral glucose tolerance testing. Lancet Diabetes Endocrinol. 2016;4:560\u20132.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"4711_CR7","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1399-5448.2009.00630.x","volume":"11","author":"AA Soros","year":"2010","unstructured":"Soros AA, Chalew SA, McCarter RJ, et al. Hemoglobin glycation index: a robust measure of hemoglobin A1c bias in pediatric type 1 diabetes patients. Pediatr Diabetes. 2010;11:455\u201361.","journal-title":"Pediatr Diabetes"},{"key":"4711_CR8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jdiacomp.2005.01.004","volume":"19","author":"SA Chalew","year":"2005","unstructured":"Chalew SA, McCarter RJ, Thomas J, et al. A comparison of the Glycosylation Gap and Hemoglobin Glycation Index in patients with diabetes. J Diabetes Complications. 2005;19:218\u201322.","journal-title":"J Diabetes Complications"},{"key":"4711_CR9","doi-asserted-by":"publisher","first-page":"604","DOI":"10.2337\/dc17-2252","volume":"41","author":"S Basu","year":"2018","unstructured":"Basu S, Raghavan S, Wexler DJ, et al. Characteristics Associated With Decreased or Increased Mortality Risk From Glycemic Therapy Among Patients With Type 2 Diabetes and High Cardiovascular Risk: Machine Learning Analysis of the ACCORD Trial. Diabetes Care. 2018;41:604\u201312.","journal-title":"Diabetes Care"},{"key":"4711_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2020.107673","volume":"34","author":"L Zhang","year":"2020","unstructured":"Zhang L, Wang M, Zhang R, et al. Hemoglobin glycation index in relationship to the risk of cardiovascular complication in patients with type 2 diabetes: A systematic review and meta-analysis. J Diabetes Complications. 2020;34: 107673.","journal-title":"J Diabetes Complications"},{"key":"4711_CR11","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.2337\/diacare.27.10.2569","volume":"27","author":"PJ Twomey","year":"2004","unstructured":"Twomey PJ, Viljoen A, Reynolds TM, et al. Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes. Diabetes Care. 2004;27:2569\u201370.","journal-title":"Diabetes Care"},{"key":"4711_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41597-022-01899-x","volume":"10","author":"AEW Johnson","year":"2023","unstructured":"Johnson AEW, Bulgarelli L, Shen L, et al. MIMIC-IV, a freely accessible electronic health record dataset. Sci Data. 2023;10:1.","journal-title":"Sci Data"},{"key":"4711_CR13","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.4067","volume":"30","author":"IR White","year":"2011","unstructured":"White IR, Royston P, Wood AM. Multiple imputation using chained equations: Issues and guidance for practice. Stat Med. 2011;30:377\u201399.","journal-title":"Stat Med"},{"key":"4711_CR14","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10:7252\u20139.","journal-title":"Clin Cancer Res"},{"key":"4711_CR15","doi-asserted-by":"crossref","unstructured":"Aktaa S, Polovina M, Rosano G, et al. European Society of Cardiology quality indicators for the care and outcomes of adults with heart failure. Developed by the Working Group for Heart Failure Quality Indicators in collaboration with the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2022;24:132\u2013142.","DOI":"10.1002\/ejhf.2371"},{"key":"4711_CR16","doi-asserted-by":"crossref","unstructured":"ElSayed NA, Aleppo G, Aroda VR, et al. 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2023. Diabetes Care. 2023;46:S49-s67.","DOI":"10.2337\/dc23-S004"},{"key":"4711_CR17","doi-asserted-by":"crossref","unstructured":"Lee Jia Jia I, Zampetti S, Pozzilli P, et al. Type 2 diabetes in children and adolescents: Challenges for treatment and potential solutions. Diabetes Res Clin Pract. 2024;217:111879.","DOI":"10.1016\/j.diabres.2024.111879"},{"key":"4711_CR18","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.2337\/dc15-2727","volume":"39","author":"KJ Welsh","year":"2016","unstructured":"Welsh KJ, Kirkman MS, Sacks DB. Role of Glycated Proteins in the Diagnosis and Management of Diabetes: Research Gaps and Future Directions. Diabetes Care. 2016;39:1299\u2013306.","journal-title":"Diabetes Care"},{"key":"4711_CR19","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.2337\/dc18-1581","volume":"41","author":"RM Bergenstal","year":"2018","unstructured":"Bergenstal RM, Beck RW, Close KL, et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care. 2018;41:2275\u201380.","journal-title":"Diabetes Care"},{"key":"4711_CR20","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s11606-013-2595-x","volume":"29","author":"MS Radin","year":"2014","unstructured":"Radin MS. Pitfalls in hemoglobin A1c measurement: when results may be misleading. J Gen Intern Med. 2014;29:388\u201394.","journal-title":"J Gen Intern Med"},{"key":"4711_CR21","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S1056-8727(01)00227-6","volume":"16","author":"JM Hempe","year":"2002","unstructured":"Hempe JM, Gomez R, McCarter RJ Jr, et al. High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control. J Diabetes Complications. 2002;16:313\u201320.","journal-title":"J Diabetes Complications"},{"key":"4711_CR22","doi-asserted-by":"publisher","first-page":"79576","DOI":"10.18632\/oncotarget.18572","volume":"8","author":"TV Fiorentino","year":"2017","unstructured":"Fiorentino TV, Marini MA, Succurro E, et al. Elevated hemoglobin glycation index identify non-diabetic individuals at increased risk of kidney dysfunction. Oncotarget. 2017;8:79576\u201386.","journal-title":"Oncotarget"},{"key":"4711_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.diabres.2017.09.017","volume":"134","author":"TV Fiorentino","year":"2017","unstructured":"Fiorentino TV, Marini MA, Succurro E, et al. Association between hemoglobin glycation index and hepatic steatosis in non-diabetic individuals. Diabetes Res Clin Pract. 2017;134:53\u201361.","journal-title":"Diabetes Res Clin Pract"},{"key":"4711_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.299","volume":"4","author":"JM Hempe","year":"2021","unstructured":"Hempe JM, Yang S, Liu S, et al. Standardizing the haemoglobin glycation index. Endocrinol Diabetes Metab. 2021;4: e00299.","journal-title":"Endocrinol Diabetes Metab"},{"key":"4711_CR25","doi-asserted-by":"crossref","unstructured":"Wang P, Li Q, Guo X, et al. The Value of Hemoglobin Glycation Index-Diabetes Mellitus System in Evaluating and Predicting Incident Stroke in the Chinese Population. J Clin Med. 2022;11(19):5814.","DOI":"10.3390\/jcm11195814"},{"key":"4711_CR26","doi-asserted-by":"crossref","unstructured":"Klein KR, Franek E, Marso S, et al. Hemoglobin glycation index, calculated from a single fasting glucose value, as a prediction tool for severe hypoglycemia and major adverse cardiovascular events in DEVOTE. BMJ Open Diabetes Res Care. 2021;9(2):e002339.","DOI":"10.1136\/bmjdrc-2021-002339"},{"key":"4711_CR27","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.jdiacomp.2018.08.007","volume":"32","author":"MK Kim","year":"2018","unstructured":"Kim MK, Jeong JS, Yun JS, et al. Hemoglobin glycation index predicts cardiovascular disease in people with type 2 diabetes mellitus: A 10-year longitudinal cohort study. J Diabetes Complications. 2018;32:906\u201310.","journal-title":"J Diabetes Complications"},{"key":"4711_CR28","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1210\/clinem\/dgab703","volume":"107","author":"L Lyu","year":"2022","unstructured":"Lyu L, Yu J, Liu Y, et al. High Hemoglobin Glycation Index Is Associated With Telomere Attrition Independent of HbA1c, Mediated by TNF\u03b1. J Clin Endocrinol Metab. 2022;107:462\u201373.","journal-title":"J Clin Endocrinol Metab"},{"key":"4711_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175547","volume":"12","author":"MA Marini","year":"2017","unstructured":"Marini MA, Fiorentino TV, Succurro E, et al. Association between hemoglobin glycation index with insulin resistance and carotid atherosclerosis in non-diabetic individuals. PLoS ONE. 2017;12: e0175547.","journal-title":"PLoS ONE"},{"key":"4711_CR30","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1097\/CM9.0000000000002717","volume":"136","author":"Y Wang","year":"2023","unstructured":"Wang Y, Liu H, Hu X, et al. Association between hemoglobin glycation index and 5-year major adverse cardiovascular events: the REACTION cohort study. Chin Med J (Engl). 2023;136:2468\u201375.","journal-title":"Chin Med J (Engl)"},{"key":"4711_CR31","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12933-024-02206-1","volume":"23","author":"X Wei","year":"2024","unstructured":"Wei X, Chen X, Zhang Z, et al. Risk analysis of the association between different hemoglobin glycation index and poor prognosis in critical patients with coronary heart disease-A study based on the MIMIC-IV database. Cardiovasc Diabetol. 2024;23:113.","journal-title":"Cardiovasc Diabetol"},{"key":"4711_CR32","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1080\/01616412.2018.1453991","volume":"40","author":"Y Pan","year":"2018","unstructured":"Pan Y, Jing J, Wang Y, et al. Association of hemoglobin glycation index with outcomes of acute ischemic stroke in type 2 diabetic patients. Neurol Res. 2018;40:573\u201380.","journal-title":"Neurol Res"},{"issue":"1","key":"4711_CR33","doi-asserted-by":"publisher","first-page":"2330615","DOI":"10.1080\/07853890.2024.2330615","volume":"56","author":"W Cheng","year":"2024","unstructured":"Cheng W, Huang R, Pu Y, et al. Association between the haemoglobin glycation index (HGI) and clinical outcomes in patients with acute decompensated heart failure. Ann Med. 2024;56(1):2330615.","journal-title":"Ann Med"},{"key":"4711_CR34","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2337\/diacare.26.1.163","volume":"26","author":"RM Cohen","year":"2003","unstructured":"Cohen RM, Holmes YR, Chenier TC, et al. Discordance between HbA1c and fructosamine: evidence for a glycosylation gap and its relation to diabetic nephropathy. Diabetes Care. 2003;26:163\u20137.","journal-title":"Diabetes Care"},{"key":"4711_CR35","doi-asserted-by":"publisher","first-page":"526","DOI":"10.2337\/dci16-0043","volume":"40","author":"ZT Bloomgarden","year":"2017","unstructured":"Bloomgarden ZT, Einhorn D, Handelsman Y. Is HbA(1c) <7% a Marker of Poor Performance in Individuals >65 Years Old? Diabetes Care. 2017;40:526\u20138.","journal-title":"Diabetes Care"},{"key":"4711_CR36","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nrcardio.2017.51","volume":"14","author":"S von Haehling","year":"2017","unstructured":"von Haehling S, Ebner N, Dos Santos MR, et al. Muscle wasting and cachexia in heart failure: mechanisms and therapies. Nat Rev Cardiol. 2017;14:323\u201341.","journal-title":"Nat Rev Cardiol"},{"key":"4711_CR37","first-page":"74","volume":"108","author":"MP Okoshi","year":"2017","unstructured":"Okoshi MP, Capalbo RV, Romeiro FG, et al. Cardiac Cachexia: Perspectives for Prevention and Treatment. Arq Bras Cardiol. 2017;108:74\u201380.","journal-title":"Arq Bras Cardiol"},{"key":"4711_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002383","volume":"14","author":"E Wheeler","year":"2017","unstructured":"Wheeler E, Leong A, Liu CT, et al. Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis. PLoS Med. 2017;14: e1002383.","journal-title":"PLoS Med"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04711-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-04711-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04711-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T08:38:31Z","timestamp":1745483911000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-04711-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4711"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-04711-x","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"assertion":[{"value":"19 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the guidelines of the Helsinki Declaration. The MIMIC-IV database was supported by grants from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) of the National Institutes of Health (NIH) under award numbers R01-EB001659 (2003\u20132013) and R01-EB017205 (2014\u20132022) and approved by the Institutional Review Boards of Beth Israel Deaconess Medical Center (Boston, MA) and the Massachusetts Institute of Technology (Cambridge, MA). As the data are publicly available (in the MIMIC-IV), the ethical approval and requirement for informed consent were waived for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"317"}}